This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ismail, E. A. R. Articles by Al-saleh, Q. Search for Related Content PubMed PubMed Citation Articles by Ismail, E. A. R. Articles by Al-saleh, Q. Social Bookmarking                         What's this?

An Epidemiologic, Clinical, and Therapeutic Study of Childhood Guillain-Barré Syndrome in Kuwait: Is It Related to the Oral Polio Vaccine?

Department of Pediatrics, Farwaniya Hospital

Issa S. Shabani, MRCP

Mubarak Hospital

Mona Badawi, MRCP

Adan Hospital

Hala Sanaa, MRCP

Amiri Hospital

Samir Madi, MD

Jahra Hospital

Asmaa Al-Tawari, MRCP

Pediatric Neurology Department, Sabah Hospital Kuwait

Hani Nadi, MRCP

Department of Pediatrics, Farwaniya Hospital

Mohamed Zaki, FRCP

Department of Pediatrics, Farwaniya Hospital

Qusai Al-saleh, FRCP

Department of Pediatrics, Farwaniya Hospital

We studied Guillain-Barré syndrome, affecting children 12 years old or less, throughout Kuwait, in the period between January 1, 1992, and March 31, 1997. Nineteen children had the diagnostic criteria of Guillain-Barré syndrome, with an overall annual incidence rate of 0.95/100,000 population at risk. Female patients outnumbered male patients with a sex ratio of 1.4:1. There was a clustering of cases in winter and spring and in the year 1996. The disease symptoms were relatively severe in our patients because only 16% (3 of 19) of them were able to walk at the height of their illness, whereas the rest were bed or chair bound or needed assisted ventilation. Two patients had the electrodiagnostic features of axonal neuropathy and both had residual deficits on follow-up, whereas the rest recovered fully. All the patients received intravenous immunoglobulin. The mean time to walk unaided was 23.5 days (range, 2-84 days) after intravenous immunoglobulin and excluding the two patients with axonal neuropathy, and full recovery was achieved in a mean time of 103 days (range, 30-300 days). Contrary to previous studies, we found no correlation between oral polio vaccine administration and Guillain-Barré syndrome in 2 successive years (1995 and 1996) during a nationwide campaign targeting children less than 5 years old. (J Child Neut-ol 1998; 13:488-492).

Journal of Child Neurology, Vol. 13, No. 10, 488-492 (1998)
DOI: 10.1177/088307389801301004


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?